Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.62 |
| ▸ | F2 | P00734 | 4/20 | 0.59 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.58 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.58 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.56 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.56 |
| ▸ | MC4R | P32245 | 1/20 | 0.54 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30233411 | 0.93 | CALCR (0.63) | CALCRF2OPRM1OPRD1HCRTR1 | |
| SCHEMBL29843080 | 0.91 | CALCR (0.60) | CALCRF2OPRM1OPRD1HCRTR1 | |
| SCHEMBL30233337 | 0.91 | CALCR (0.60) | CALCRF2OPRM1OPRD1HCRTR1 | |
| SCHEMBL30233460 | 0.90 | CALCR (0.59) | CALCRF2OPRM1OPRD1HCRTR1 | |
| SCHEMBL30233281 | 0.90 | C5AR1 (0.63) | CALCRF2HCRTR1HCRTR2MC4R | |
| SCHEMBL30233179 | 0.89 | CXCR4 (0.57) | CALCRMC4RC5AR1 | |
| SCHEMBL29842938 | 0.89 | CALCR (0.58) | CALCRF2OPRM1OPRD1HCRTR1 | |
| SCHEMBL30607475 | 0.89 | CALCR (0.69) | CALCRF2OPRM1OPRD1HCRTR1 | |
| SCHEMBL30233449 | 0.89 | CALCR (0.58) | CALCRF2OPRM1OPRD1C5AR1 | |
| SCHEMBL30788340 | 0.88 | F2 (0.59) | CALCRF2HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115702161-A | Peptide compositions and methods for inhibiting nicotinic acetylcholine receptor activity | 格罗制药公司 | 2023-02-14 | — | — | CN | disclosed |